{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "70954-148",
      "generic_name": "Pyridostigmine bromide oral",
      "labeler_name": "Novitium Pharma LLC",
      "brand_name": "Pyridostigmine",
      "active_ingredients": [
        {
          "name": "PYRIDOSTIGMINE BROMIDE",
          "strength": "60 mg/5mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "70954-148-10",
          "description": "473 mL in 1 BOTTLE (70954-148-10)",
          "marketing_start_date": "20190311",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Novitium Pharma LLC"
        ],
        "rxcui": [
          "903843"
        ],
        "spl_set_id": [
          "ef78ff05-8e0f-463a-88cd-ca9a01aed76a"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "KVI301NA53"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "SOLUTION",
      "spl_id": "ef78ff05-8e0f-463a-88cd-ca9a01aed76a",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20190311",
      "product_id": "70954-148_ef78ff05-8e0f-463a-88cd-ca9a01aed76a",
      "application_number": "ANDA211694",
      "brand_name_base": "Pyridostigmine",
      "pharm_class": [
        "Cholinesterase Inhibitor [EPC]",
        "Cholinesterase Inhibitors [MoA]"
      ]
    }
  ]
}